Natalizumab 150mg/1ml solution for injection pre-filled syringes
NHS hospitals in England used £23,248,055 of indicative cost of Natalizumab 150mg/1ml solution for injection pre-filled syringes in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 17.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Natalizumab 150mg/1ml solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Natalizumab 150mg/1ml solution for injection pre-filled syringes most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| University Hpls Coventry & Warwick Trust | £1,623,810 |
| University Hospital Southampton Nhs Ft | £1,623,810 |
| Univ Hpl B/Ham Nhs Foundation Trust | £1,534,540 |
| Salford Royal Nhs Foundation Trust | £1,163,900 |
| Derby Teaching Hospitals Nhs Found Trust | £997,790 |
| North Bristol Nhs Trust | £963,890 |
| Cambridge Univ Hosp Nhs Foundation Trust | £912,475 |
| Sheffield Teaching Hospitals Nhs Trust | £869,535 |
| University Hpls North Midlands Nhs Trust | £802,300 |
| University College London Foundation Tr | £791,565 |
The primary-care picture
Natalizumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Natalizumab medicine page.